Company ViaDerma, Inc. Other OTC
Equities
VDRM
US92555K1016
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Topical Antibiotic
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +11.07% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +11.07% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chris Ayo Otiko
CEO | Chief Executive Officer | - | 14-03-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Ayo Otiko
CEO | Chief Executive Officer | - | 14-03-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,233,713,103 | 1,221,375,971 ( 99.00 %) | 0 | 99.00 % |
Company contact information
ViaDerma, Inc.
4640 Admiralty Way Suite 500
90292, Marina Del Rey
+
Sector
1st Jan change | Capi. | |
---|---|---|
+48.64% | 54.63B | |
-6.44% | 39.92B | |
+37.07% | 38.82B | |
+14.28% | 26.86B | |
-11.17% | 26.22B | |
-21.40% | 18.78B | |
+25.64% | 12.21B | |
+0.96% | 12.16B | |
+27.04% | 11.94B |